The official news source of

ACR Convergence 2023

San Diego, CA

Register Now

Meeting Home

Register Now

Home // Events // RestoreD: A clinical trial with oral ALXN2050 – a Complement Factor D inhibitor – for Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (lgAN)

RestoreD: A clinical trial with oral ALXN2050 – a Complement Factor D inhibitor – for Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (lgAN)

Name: RestoreD: A clinical trial with oral ALXN2050 – a Complement Factor D inhibitor – for Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (lgAN)
Start: 2023-11-13T13:18:00-08:00
End: 2023-11-13T13:23:00-08:00

October 26, 2023

1 minute